Metabolic imprinting in beef calves supplemented with creep feeding on performance, reproductive efficiency and metabolome profile.

This experiment evaluated the influence of creep feeding supplementation on productive and reproductive performance and on serum metabolome profile in Nelore (Bos indicus) heifers. Female calves were assigned to treatments: Creep (n = 190), with ad libitum access to a nutritional supplement from 70 to 220 days after birth, or Control (n = 140), without supplementation. After weaning (Day 220), both groups followed the same pasture and nutritional management. Body weight (BW) and backfat thickness (BFAT) were measured over time. Blood samples were collected at 220 and 360 days for LC-MS/MS targeted metabolomics. On day 408, during the synchronization timed artificial insemination (TAI) protocol, reproductive status (RS: diameter of uterine horn and largest follicle, and presence of CL) was assessed. Creep feeding increased BW and BFAT at weaning, but no differences in BW, BFAT, or RS after weaning were observed. Nonetheless, the pregnancy per AI (P/AI) for 1st service was 28.9% higher in the Creep group. On day 220, 11 significant metabolites influenced five metabolic pathways: Glucose-alanine cycle, alanine, glutathione, phenylalanine and tyrosine metabolism, and urea cycle. On day 360, 14 significant metabolites influenced eight metabolic pathways: Malate-aspartate shuttle, arginine and proline metabolism, urea cycle, aspartate, beta-alanine, glutamate metabolism, ammonia recycling and citric acid cycle. In conclusion, creep feeding supplementation improved calf performance and induced metabolic changes at weaning and 360 days of age. Although heifers had similar productive performance and reproductive status, when submitted to TAI, those supplemented with creep feeding had greater P/AI.

Use of new recombinant proteins for ovarian stimulation in ruminants.

Currently, gonadotropin products (follicle stimulating hormone, FSH, and luteinizing hormone, LH) used in animal reproduction are produced by extraction and purification from abattoir-derived pituitary glands. This method, relying on animal-derived materials, carries the potential risk of hormone contamination and pathogen transmission. Additionally, chorionic gonadotropins are extracted from the blood of pregnant mares (equine chorionic gonadotropin; eCG) or the urine of pregnant women (human chorionic gonadotropin; hCG). However, recent advancements have introduced recombinant gonadotropins for assisted animal reproduction therapies. The traditional use of FSH for superovulation has limitations, including labor requirements and variability in superovulation response, affecting the success of in vivo (SOV) and in vitro (OPU/IVEP) embryo production. FSH treatment for superstimulation before OPU can promote the growth of a homogenous follicular population and the recovery of competent oocytes suitable for IVEP procedures. At present, a single injection of a preparation of long-acting bovine recombinant FSH (rFSH) produced similar superovulation responses resulting in the production of good-quality in vivo and in vitro embryos. Furthermore, the treatment with eCG at FTAI protocol has demonstrated its efficacy in promoting follicular growth, ovulation, and P/AI, mainly in heifers and anestrous cows. Currently, treatment with recombinant glycoproteins with eCG-like activity (r-eCG) have shown promising results in increasing follicular growth, ovulation, and P/AI in cows submitted to P4/E2 -based protocols. Bovine somatotropin (bST) is a naturally occurring hormone found in cows. Recombinant bovine somatotropin (rbST), produced through genetic engineering techniques, has shown potential in enhancing reproductive outcomes in ruminants. Treatment with rbST has been found to improve P/IA, increase donor embryo production, and enhance P/ET in recipients. The use of recombinant hormones allows to produce non-animal-derived products, offering several advantages in assisted reproductive technologies for ruminants. This advancement opens up new possibilities for improving reproductive efficiency and success rates in the field of animal reproduction.

Use of new recombinant proteins for ovarian stimulation in ruminants

Currently, gonadotropin products (follicle stimulating hormone, FSH, and luteinizing hormone, LH) used in animal reproduction are produced by extraction and purification from abattoir-derived pituitary glands. This method, relying on animal-derived materials, carries the potential risk of hormone contamination and pathogen transmission. Additionally, chorionic gonadotropins are extracted from the blood of pregnant mares (equine chorionic gonadotropin; eCG) or the urine of pregnant women (human chorionic gonadotropin; hCG). However, recent advancements have introduced recombinant gonadotropins for assisted animal reproduction therapies. The traditional use of FSH for superovulation has limitations, including labor requirements and variability in superovulation response, affecting the success of in vivo (SOV) and in vitro (OPU/IVEP) embryo production. FSH treatment for superstimulation before OPU can promote the growth of a homogenous follicular population and the recovery of competent oocytes suitable for IVEP procedures. At present, a single injection of a preparation of long-acting bovine recombinant FSH (rFSH) produced similar superovulation responses resulting in the production of good-quality in vivo and in vitro embryos. Furthermore, the treatment with eCG at FTAI protocol has demonstrated its efficacy in promoting follicular growth, ovulation, and P/AI, mainly in heifers and anestrous cows. Currently, treatment with recombinant glycoproteins with eCG-like activity (r-eCG) have shown promising results in increasing follicular growth, ovulation, and P/AI in cows submitted to P4/E2 -based protocols. Bovine somatotropin (bST) is a naturally occurring hormone found in cows. Recombinant bovine somatotropin (rbST), produced through genetic engineering techniques, has shown potential in enhancing reproductive outcomes in ruminants. Treatment with rbST has been found to improve P/IA, increase donor embryo production, and enhance P/ET in recipients. The use of recombinant hormones allows to produce non-animal-derived products, offering several advantages in assisted reproductive technologies for ruminants. This advancement opens up new possibilities for improving reproductive efficiency and success rates in the field of animal reproduction.(AU)

IATF em números: evolução e projeção futura / FTAI in numbers: evolution and future projection

Estudos realizados pelo Departamento de Reprodução Animal da Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ/USP) apontam que a IATF (inseminação artificial em tempo fixo) atingiu mais um recorde em 2021 e superou 26 milhões de procedimentos de sincronização. O mercado de IATF cresceu 25% entre 2020 e 2021 e representou 93% das inseminações efetuadas no Brasil. A tecnologia de IATF proporciona uma abordagem organizada e prática para o uso da inseminação artificial (IA), além de melhorar a eficiência reprodutiva, genética e produtiva dos rebanhos. Segundo dados da ASBIA (Associação Brasileira de Inseminação Artificial), em 2002 o mercado nacional de IA comercializou 7,1 milhões de doses de sêmen, para um rebanho estimado de 74,9 milhões de matrizes (vacas e novilhas; ANUALPEC). Em 2021, com rebanho semelhante de matrizes, o mercado atingiu 28,4 milhões de doses de sêmen comercializadas, com crescimento de 400% nesse período. Em 2002, apenas 5,8% das matrizes de leite e de corte do rebanho brasileiro eram inseminadas artificialmente. Em 2021, foram inseminadas 23,4% das fêmeas do total das matrizes do rebanho nacional. No início das avaliações (2002), 4.4 milhões de matrizes bovinas eram inseminadas artificialmente no Brasil, atingindo 17.5 milhões de matrizes em 2021. Entre 2002 e 2021, a taxa de crescimento anual composta (CAGR: Compound Annual Growth Rate) do número de protocolos de sincronização comercializados para IATF foi de 34,1%. Essas informações demonstram a significativa evolução da utilização da IA e a consolidação da tecnologia pelo setor produtivo.(AU)

Studies carried out by the Department of Animal Reproduction of the Faculty of Veterinary Medicine and Animal Science of the University of São Paulo (FMVZ/USP) indicate that FTAI (fixed-time artificial insemination) reached another record in 2021 and exceeded 26 million synchronization protocols. The FTAI market grew increased 25% between 2020 and 2021 and represented 93% of all inseminations performed in Brazil. FTAI technology provides an organized and practical approach to the use of artificial insemination (AI), in addition to improving the reproductive, genetic and productive efficiency of herds. According to data from ASBIA (Brazilian Association of Artificial Insemination), in 2002 the national AI market sold 7.1 million doses of semen to an estimated herd of 74.9 million females (cows and heifers; ANUALPEC). In 2021, with a similar number of females, the market reached 28.4 million doses of semen sold, with growth of 400% in this period. In 2002, only 5.8% of dairy and beef females in the Brazilian herd were artificially inseminated. In 2021, 23.4% of the females of the total number of females in the national herd were inseminated (4 times growth). At the beginning of the evaluations (2002), 4.4 million females were artificially inseminated in Brazil, reaching 17.5 million cows and heifers in 2021. Between 2002 and 2021, the Compound Annual Growth Rate (CAGR) of the number of synchronization protocols marketed was 34.1%. This information demonstrates the significant evolution of the use of AI and the consolidation of FTAI technology by the productive sector.(AU)

Mitos e realidades sobre a inseminação artificial em tempo fixo (IATF) em bovinos de corte / Myths and realities of timed artificial insemination in beef cattle

O sistema de cria é um dos principais setores da bovinocultura de corte, com impactos diretos na ocupação da terra (70% das pastagens são ocupadas pela cria) e na produtividade da cadeia da carne. O número e o peso dos bezerros produzidos por matriz e a idade das novilhas ao primeiro parto influenciam diretamente a eficiência do setor. As biotecnologias da reprodução, com destaque para a inseminação artificial em tempo fixo (IATF), têm colaborado significativamente para o desenvolvimento de um sistema de produção cada vez mais eficiente e sustentável. Em 2020 foram comercializadas no Brasil 23,7 milhões de doses de sêmen e 21,3 milhões de protocolos de IATF (90% das inseminações foram realizadas por IATF). Em 2002 eram utilizados apenas 100 mil procedimentos de IATF, que representavam somente 1% das inseminações realizadas. Nesse mesmo período (2002 a 2020), o percentual de matrizes inseminadas passou de 5% para 20% (acréscimo de 400%), com aumento de 213 vezes no empego da IATF. Os programas de IATF oferecem uma abordagem organizada e prática para o uso da IA, além de melhorarem a eficiência reprodutiva, genética e produtiva dos rebanhos. O uso da IATF antecipa a prenhez na estação de monta e a idade a primeira concepção das novilhas, aumentando significativamente a eficiência reprodutiva, produtiva e o retorno econômico do setor. Recentes estudos evidenciaram que os sistemas de cria que utilizam a IATF apresentam redução de 37,7% na emissão de CO2 equivalentes (produz mais bezerros de qualidade genética com menos matrizes que a monta natural), colaborando com a sustentabilidade da pecuária. Evidencia-se, também, que a nutrição, além de outros fatores, exerce papel importante na reprodução e afeta diretamente o desempenho da IATF. Entretanto, ainda existem mitos e realidades sobre os fatores que podem afetar o sucesso desta biotecnologia. O objetivo dessa revisão é apresentar e discutir os principais temas que impactam a eficiência da IATF em rebanhos de corte.

The cow-calf operation system is one is one of the main sectors of beef production, with direct impacts on land occupation (70% of pastures are occupied by the cow-calf operation system) and on the productivity of the meat chain. The number and the weight of calves produced per cow and the age of the heifer at first calving directly impact the efficiency of the sector. Reproductive biotechnologies, with emphasis on fixed-time artificial insemination (FTAI), have significantly contributed to the development of an efficient and sustainable production system. In 2020, 23.7 million doses of semen and 21.3 million FTAI protocols were marketed in Brazil (90% of inseminations were performed by FTAI). In 2002, only 100,000 FTAI procedures were used (a 213-fold increase in 19 years), which represented only 1% of the inseminations performed. During this same period (2002 to 2020), Brazil went from 5% to 20% of inseminated cow and heifers (increase of 400%). FTAI programs provide an organized and practical approach to the use of AI, as well as improve the reproductive, genetic and productive efficiency of the herds. The use of the FTAI anticipates the conception of cows in the breeding season and the age of the first conception of heifers, significantly increasing the reproductive and productive efficiency and the economic return of livestock. Recent studies have shown that breeding systems that use FTAI present a reduction of 37.7% in the emission of CO2 equivalents (it produces more calves of genetic quality with fewer dams than natural service), collaborating and with the sustainability of livestock. It is also evident that nutrition plays an important role in reproduction and directly affects the FTAI performance. However, there are still myths and realities about the factors that can affect the success of this biotechnology. The aim of this review is to present and discuss the main topics that impact the efficiency of FTAI in beef herds.

Challenges to increase the AI and ET markets in Brazil.

Artificial insemination (AI) and embryo transfer (ET) are the most widely used biotechnologies in the world with the goal of increasing genetic gain and improving reproductive efficiency of beef and dairy herds. The protocols for ovulation synchronization for timed AI (TAI) or ET (TET) are tools that allow artificial insemination or transfer of a high number of embryos in a pre-established moment and without the necessity of estrous detection. Currently, 86% of inseminations in Brazil are performed using TAI (13.6 million TAI out of a total of 15.4 million doses of semen marketed in 2018). With the use of TAI, it was possible to verify that the percentage of artificially inseminated females in Brazil went from 5.8% in 2002 to 13.1% in 2018. The ET market also presented considerable growth in the last 20 years. There was an increase of approximately 8 fold in the number of produced embryos, escalating from 50,000 in 1999 to 375,000 in 2017. In this period, there was a significant increase on the in vitro embryo production, which represented 92.1% of embryos produced in Brazil in 2017. Also, in this period, there was an increase on the embryo production of dairy breeds and reduction on the embryo production of zebu breeds in comparison to data from the early 2000's. TET increases significantly the number of recipients suitable to receive an embryo. After synchronization, 75 to 85% of recipients present a suitable CL for ET without estrous detection. Currently, many synchronization and resynchronization protocols for TAI/TET have been studied to attend different managements, breeds and animal categories, with predictable and satisfactory results. With the intensification of the use of these biotechnologies, it is possible to obtain elevated reproductive efficiency with increase on the genetic gain, which determines greater productivity and economic return for dairy and beef farms. However, the challenge to keep the market growing in the next decade could depend on some factors, such as: increase of the extension services for producers and of the extension training for specialists, improvement of the technological advances to develop more efficient and cost-effective products and practical protocols, increase the integration between universities, research institutes, veterinarians and industries and also, asses market demand for production of animal protein with higher quality, efficiency and environmental and economic sustainability.

Challenges to increase the AI and ET markets in Brazil

Artificial insemination (AI) and embryo transfer (ET) are the most widely used biotechnologies in the world with the goal of increasing genetic gain and improving reproductive efficiency of beef and dairy herds. The protocols for ovulation synchronization for timed AI (TAI) or ET (TET) are tools that allow artificial insemination or transfer of a high number of embryos in a pre-established moment and without the necessity of estrous detection. Currently, 86% of inseminations in Brazil are performed using TAI (13.6 million TAI out of a total of 15.4 million doses of semen marketed in 2018). With the use of TAI, it was possible to verify that the percentage of artificially inseminated females in Brazil went from 5.8% in 2002 to 13.1% in 2018. The ET market also presented considerable growth in the last 20 years. There was an increase of approximately 8 fold in the number of produced embryos, escalating from 50,000 in 1999 to 375,000 in 2017. In this period, there was a significant increase on the in vitro embryo production, which represented 92.1% of embryos produced in Brazil in 2017. Also, in this period, there was an increase on the embryo production of dairy breeds and reduction on the embryo production of zebu breeds in comparison to data from the early 2000s. TET increases significantly the number of recipients suitable to receive an embryo. After synchronization, 75 to 85% of recipients present a suitable CL for ET without estrous detection. Currently, many synchronization and resynchronization protocols for TAI/TET have been studied to attend different managements, breeds and animal categories, with predictable and satisfactory results. With the intensification of the use of these biotechnologies, it is possible to obtain elevated reproductive efficiency with increase on the genetic gain, which determines greater productivity and economic return for dairy and beef farms. However, the challenge to keep the market growing in the next decade could depend on some factors, such as: increase of the extension services for producers and of the extension training for specialists, improvement of the technological advances to develop more efficient and cost-effective products and practical protocols, increase the integration between universities, research institutes, veterinarians and industries and also, asses market demand for production of animal protein with higher quality, efficiency and environmental and economic sustainability.(AU)

Challenges to increase the AI and ET markets in Brazil

Artificial insemination (AI) and embryo transfer (ET) are the most widely used biotechnologies in the world with the goal of increasing genetic gain and improving reproductive efficiency of beef and dairy herds. The protocols for ovulation synchronization for timed AI (TAI) or ET (TET) are tools that allow artificial insemination or transfer of a high number of embryos in a pre-established moment and without the necessity of estrous detection. Currently, 86% of inseminations in Brazil are performed using TAI (13.6 million TAI out of a total of 15.4 million doses of semen marketed in 2018). With the use of TAI, it was possible to verify that the percentage of artificially inseminated females in Brazil went from 5.8% in 2002 to 13.1% in 2018. The ET market also presented considerable growth in the last 20 years. There was an increase of approximately 8 fold in the number of produced embryos, escalating from 50,000 in 1999 to 375,000 in 2017. In this period, there was a significant increase on the in vitro embryo production, which represented 92.1% of embryos produced in Brazil in 2017. Also, in this period, there was an increase on the embryo production of dairy breeds and reduction on the embryo production of zebu breeds in comparison to data from the early 2000’s. TET increases significantly the number of recipients suitable to receive an embryo. After synchronization, 75 to 85% of recipients present a suitable CL for ET without estrous detection. Currently, many synchronization and resynchronization protocols for TAI/TET have been studied to attend different managements, breeds and animal categories, with predictable and satisfactory results. With the intensification of the use of these biotechnologies, it is possible to obtain elevated reproductive efficiency with increase on the genetic gain, which determines greater productivity and economic return for dairy and beef farms. However, the challenge to keep the market growing in the next decade could depend on some factors, such as: increase of the extension services for producers and of the extension training for specialists, improvement of the technological advances to develop more efficient and cost-effective products and practical protocols, increase the integration between universities, research institutes, veterinarians and industries and also, asses market demand for production of animal protein with higher quality, efficiency and environmental and economic sustainability.

Evolução e perspectivas da inseminação artificial em bovinos / Evolution and perspectives of timed artificial insemination in cattle

A inseminação artificial (IA) em bovinos tem sido aplicada em todo o mundo com o intuito de melhorar o ganho genético e a eficiência reprodutiva dos rebanhos. Com o objetivo de facilitar a utilização da IA foram desenvolvidos protocolos de inseminação artificial em tempo fixo (IATF) que promovem o controle do crescimento folicular e da ovulação e permitem a aplicação da IA em dias predeterminados, sem a necessidade de detecção de estro e com elevadas taxas de prenhez. Nos últimos 20 anos, vários protocolos de sincronização para IATF foram estudados para atender diferentes realidades de manejo, raças e categorias de animais. Atualmente, 86% das inseminações no Brasil estão sendo realizadas por IATF (13,6 milhões de IATF de um total de 15,4 milhões de doses de sêmen comercializadas em 2018). Com a colaboração dessa tecnologia, verificou-se que o percentual de fêmeas em idade reprodutiva inseminadas artificialmente passou de 5,8% em 2002 para 13,1% em 2018. O aumento de uso da IATF representa considerável incremento de produtividade quando comparado com a monta natural, maximizando o retorno econômico para as fazendas de corte e de leite.(AU)

Artificial insemination in cattle has been used worldwide to improve the genetic gain and reproductive efficiency of the herds. In order to facilitate the use of AI, several protocols for timed artificial insemination (TAI) have been developed, which promote the control of follicular growth and ovulation, allowing the use of AI in predetermined days, without the necessity of estrus detection and with satisfactory pregnancy rates. In the last 20 years, a wide variety of protocols have been studied to address different management realities, breeds and animal categories. Currently, 86% of artificial inseminations in Brazil are performed using TAI (13.6 million TAI of 15.4 million batches of semen commercialized in 2018). The percentage of females in reproductive age inseminated in Brazil went from 5.8% in 2002 to 13.1% in 2018. Reproductive programs that use TAI present increase in productivity when compared to natural breeding, maximizing the economic gain for beef and dairy properties.(AU)

Evolução e perspectivas da inseminação artificial em bovinos / Evolution and perspectives of timed artificial insemination in cattle

A inseminação artificial (IA) em bovinos tem sido aplicada em todo o mundo com o intuito de melhorar o ganho genético e a eficiência reprodutiva dos rebanhos. Com o objetivo de facilitar a utilização da IA foram desenvolvidos protocolos de inseminação artificial em tempo fixo (IATF) que promovem o controle do crescimento folicular e da ovulação e permitem a aplicação da IA em dias predeterminados, sem a necessidade de detecção de estro e com elevadas taxas de prenhez. Nos últimos 20 anos, vários protocolos de sincronização para IATF foram estudados para atender diferentes realidades de manejo, raças e categorias de animais. Atualmente, 86% das inseminações no Brasil estão sendo realizadas por IATF (13,6 milhões de IATF de um total de 15,4 milhões de doses de sêmen comercializadas em 2018). Com a colaboração dessa tecnologia, verificou-se que o percentual de fêmeas em idade reprodutiva inseminadas artificialmente passou de 5,8% em 2002 para 13,1% em 2018. O aumento de uso da IATF representa considerável incremento de produtividade quando comparado com a monta natural, maximizando o retorno econômico para as fazendas de corte e de leite.

Artificial insemination in cattle has been used worldwide to improve the genetic gain and reproductive efficiency of the herds. In order to facilitate the use of AI, several protocols for timed artificial insemination (TAI) have been developed, which promote the control of follicular growth and ovulation, allowing the use of AI in predetermined days, without the necessity of estrus detection and with satisfactory pregnancy rates. In the last 20 years, a wide variety of protocols have been studied to address different management realities, breeds and animal categories. Currently, 86% of artificial inseminations in Brazil are performed using TAI (13.6 million TAI of 15.4 million batches of semen commercialized in 2018). The percentage of females in reproductive age inseminated in Brazil went from 5.8% in 2002 to 13.1% in 2018. Reproductive programs that use TAI present increase in productivity when compared to natural breeding, maximizing the economic gain for beef and dairy properties.